Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses

Hemodialysis International

Volumn 17, Issue 4, 2013, Pages 664-667

  Kohlova, Michaela ^a,b   Ribeiro, Sandra ^a,c   do Sameiro Faria, Maria ^a,d   Rocha Pereira, Petronila ^c,e   Fernandes, João ^b,c   Reis, Flávio ^b   Miranda, Vasco ^d   Quintanilha, Alexandre ^a,c   Belo, Luís ^a,c   Bronze Rocha, Elsa ^a,c   Costa, Elísio ^a,c   Santos Silva, Alice ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d Frenesius Medical Care Nephrocare Maia SA   (Portugal)

^e UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CIRCULATING CELL FREE DNA; DNA; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTIFICIAL KIDNEY; CELL FREE SYSTEM; CELL VOLUME; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; GENETIC ASSOCIATION; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; IRON METABOLISM; KIDNEY FAILURE; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEPHROSCLEROSIS; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL;

AGED; DNA; ERYTHROPOIETIN; FEMALE; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 84884978338     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12055     Document Type: Letter

References (10)

1. Costa E, Pereira BJ, Rocha-Pereira P, etal. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol. 2008; 28:677-683.
2. Costa E, Lima M, Alves JM, etal. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008; 28:268-275.
3. Jofre R, Rodriguez-Benitez P, Lopez-Gomez JM, etal. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006; 17(Suppl 3):S274-S280.
4. Junk K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta. 2010; 411:1611-1624.
5. Tovbin D, Novack V, Wiessman MP, Elkadir AA, Zlotnik M, Douvdevani A. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant. 2012; 27:3929-3935.
6. Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem. 2009; 46:488-494.
7. Atamaniuk J, Vidotto C, Tschan H, Bachl N, Stuhlmeier KM, Muller MM. Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin Chem. 2004; 50:1668-1670.
8. Jyhava J, Nevalainen T, Marttila S, Jylha M, Hervonen A, Hurme M. Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Aging Cell. 2013. DOI:10.1111/acel.12058.
9. Atamaniuk J, Kopecky C, Skoupy S, Saemann MD, Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant. 2012; 27:902-905.
10. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Kamiri A, Eigner M, Mueller MM. Cell-free plasma DNA: A marker for apoptosis during hemodialysis. Clin Chem. 2006; 52:523-526.